INOZYME PHARMA, INC. Lessee, Operating Lease, Liability, to be Paid
INOZYME PHARMA, INC. had Lessee, Operating Lease, Liability, to be Paid of $684.00 thousand as of 2025-03-31, per its 10-Q filed 2025-05-14.
Financial Statements › Notes › Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue · last filed 2025-05-14
- 2025-03-31: Lessee, Operating Lease, Liability, to be Paid $684.00K.
- 2024-12-31: Lessee, Operating Lease, Liability, to be Paid $944.00K.
- 2024-09-30: Lessee, Operating Lease, Liability, to be Paid $1.20M.
- 2024-06-30: Lessee, Operating Lease, Liability, to be Paid $1.45M.
| Period end | Lessee, Operating Lease, Liability, to be Paid |
|---|---|
| 2025-03-31 | $684.00K 10-Q · filed 2025-05-14 |
| 2024-12-31 | $944.00K 10-K · filed 2025-03-10 |
| 2024-09-30 | $1.20M 10-Q · filed 2024-11-05 |
| 2024-06-30 | $1.45M 10-Q · filed 2024-08-06 |
| 2024-03-31 | $1.71M 10-Q · filed 2024-05-07 |
| 2023-09-30 | $2.21M 10-Q · filed 2023-11-07 |
| 2023-06-30 | $2.46M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $2.70M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $2.95M 10-K · filed 2023-03-22 |
| 2022-09-30 | $3.19M 10-Q · filed 2022-11-10 |
| 2022-06-30 | $3.44M 10-Q · filed 2022-08-15 |
| 2022-03-31 | $3.68M 10-Q · filed 2022-05-10 |
| 2021-12-31 | $3.92M 10-K · filed 2022-03-15 |
| 2021-09-30 | $4.16M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $4.39M 10-Q · filed 2021-08-11 |
| 2021-03-31 | $4.63M 10-Q · filed 2021-05-12 |
| 2020-12-31 | $4.90M 10-K · filed 2021-03-25 |
| 2020-09-30 | $5.06M 10-Q · filed 2020-11-12 |
| 2020-06-30 | $4.99M 10-Q · filed 2020-09-03 |